
Jeffrey S. Lundgren
Supervisory Patent Examiner (ID: 7003, Phone: (571)272-5541 , Office: P/1629 )
| Most Active Art Unit | 1639 |
| Art Unit(s) | 1631, 1639, 1629 |
| Total Applications | 528 |
| Issued Applications | 121 |
| Pending Applications | 142 |
| Abandoned Applications | 265 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5625288
[patent_doc_number] => 20060263793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Novel linker compound, substrate coated with the compound, method of producing microarray using the compound and microarray produced by the method'
[patent_app_type] => utility
[patent_app_number] => 11/266710
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6366
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11266710
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/266710 | Linker compound, substrate coated with the compound, method of producing microarray using the compound and microarray produced by the method | Nov 2, 2005 | Issued |
Array
(
[id] => 5337786
[patent_doc_number] => 20090054250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Methods to create fluorescent biosensors using aptamers with fluorescent base analogs'
[patent_app_type] => utility
[patent_app_number] => 11/664914
[patent_app_country] => US
[patent_app_date] => 2005-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6354
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11664914
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664914 | Methods to create fluorescent biosensors using aptamers with fluorescent base analogs | Nov 1, 2005 | Abandoned |
Array
(
[id] => 5807708
[patent_doc_number] => 20060094062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Ultra high throughput capture lift screening methods'
[patent_app_type] => utility
[patent_app_number] => 11/261630
[patent_app_country] => US
[patent_app_date] => 2005-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20727
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094062.pdf
[firstpage_image] =>[orig_patent_app_number] => 11261630
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/261630 | Ultra high throughput capture lift screening methods | Oct 30, 2005 | Abandoned |
Array
(
[id] => 4916169
[patent_doc_number] => 20080096770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Evaluation of the Toxicity of Pharmaceutical Agents'
[patent_app_type] => utility
[patent_app_number] => 11/718298
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 33034
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096770.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718298
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718298 | Evaluation of the Toxicity of Pharmaceutical Agents | Oct 26, 2005 | Abandoned |
Array
(
[id] => 5632276
[patent_doc_number] => 20060148746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Nucleic acid inhibitors of glutamate receptors'
[patent_app_type] => utility
[patent_app_number] => 11/256726
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12007
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148746.pdf
[firstpage_image] =>[orig_patent_app_number] => 11256726
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/256726 | Nucleic acid inhibitors of glutamate receptors | Oct 23, 2005 | Issued |
Array
(
[id] => 4922485
[patent_doc_number] => 20080070801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Production of nano-powder based combinatorial libraries'
[patent_app_type] => utility
[patent_app_number] => 11/251562
[patent_app_country] => US
[patent_app_date] => 2005-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6774
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070801.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251562
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251562 | Production of nano-powder based combinatorial libraries | Oct 12, 2005 | Issued |
Array
(
[id] => 4797832
[patent_doc_number] => 20080009418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Selective Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/664632
[patent_app_country] => US
[patent_app_date] => 2005-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8058
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009418.pdf
[firstpage_image] =>[orig_patent_app_number] => 11664632
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664632 | Selective Inhibitors | Oct 3, 2005 | Abandoned |
Array
(
[id] => 5881470
[patent_doc_number] => 20060030553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Cell adhesion inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/234418
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37044
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20060030553.pdf
[firstpage_image] =>[orig_patent_app_number] => 11234418
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/234418 | Cell adhesion inhibitors | Sep 25, 2005 | Abandoned |
Array
(
[id] => 5710457
[patent_doc_number] => 20060051802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Artificial receptors, building blocks, and methods'
[patent_app_type] => utility
[patent_app_number] => 11/223463
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16008
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051802.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223463
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223463 | Artificial receptors, building blocks, and methods | Sep 8, 2005 | Abandoned |
Array
(
[id] => 5903232
[patent_doc_number] => 20060046271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides'
[patent_app_type] => utility
[patent_app_number] => 11/219634
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26104
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20060046271.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219634
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219634 | Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides | Sep 1, 2005 | Abandoned |
Array
(
[id] => 5785290
[patent_doc_number] => 20060205011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Combinatorial artificial receptors including tether building blocks on scaffolds'
[patent_app_type] => utility
[patent_app_number] => 11/219338
[patent_app_country] => US
[patent_app_date] => 2005-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 27630
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205011.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219338
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219338 | Combinatorial artificial receptors including tether building blocks on scaffolds | Aug 31, 2005 | Issued |
Array
(
[id] => 338024
[patent_doc_number] => 07504365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-17
[patent_title] => 'Combinatorial artificial receptors including tether building blocks'
[patent_app_type] => utility
[patent_app_number] => 11/219515
[patent_app_country] => US
[patent_app_date] => 2005-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 63
[patent_no_of_words] => 47542
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/504/07504365.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219515
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219515 | Combinatorial artificial receptors including tether building blocks | Aug 31, 2005 | Issued |
Array
(
[id] => 4999756
[patent_doc_number] => 20070042390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Method and device for critical dimension detection by molecular binding'
[patent_app_type] => utility
[patent_app_number] => 11/207351
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9014
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042390.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207351
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207351 | Method and device for critical dimension detection by molecular binding | Aug 18, 2005 | Abandoned |
Array
(
[id] => 4916166
[patent_doc_number] => 20080096767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Method For Expanding The Dynamic Detection Range In Microarrays'
[patent_app_type] => utility
[patent_app_number] => 11/575006
[patent_app_country] => US
[patent_app_date] => 2005-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1761
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096767.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575006
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575006 | Method For Expanding The Dynamic Detection Range In Microarrays | Aug 16, 2005 | Abandoned |
Array
(
[id] => 5880896
[patent_doc_number] => 20060029979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Electrochemical luminescence composite material with anti-biofouling properties'
[patent_app_type] => utility
[patent_app_number] => 11/196305
[patent_app_country] => US
[patent_app_date] => 2005-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2012
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029979.pdf
[firstpage_image] =>[orig_patent_app_number] => 11196305
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/196305 | Electrochemical luminescence composite material with anti-biofouling properties | Aug 3, 2005 | Abandoned |
Array
(
[id] => 5767602
[patent_doc_number] => 20060019291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Cloning system for construction of recombinant expression vectors'
[patent_app_type] => utility
[patent_app_number] => 11/179342
[patent_app_country] => US
[patent_app_date] => 2005-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11790
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019291.pdf
[firstpage_image] =>[orig_patent_app_number] => 11179342
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/179342 | Cloning system for construction of recombinant expression vectors | Jul 10, 2005 | Abandoned |
Array
(
[id] => 5687756
[patent_doc_number] => 20060286071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Therapeutic pastes for medical device coating'
[patent_app_type] => utility
[patent_app_number] => 11/158452
[patent_app_country] => US
[patent_app_date] => 2005-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5852
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286071.pdf
[firstpage_image] =>[orig_patent_app_number] => 11158452
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/158452 | Therapeutic pastes for medical device coating | Jun 20, 2005 | Abandoned |
Array
(
[id] => 5101210
[patent_doc_number] => 20070184472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Method of purifying environmental dna and method of efficiently screening for protein-encoding gene from environmental dna'
[patent_app_type] => utility
[patent_app_number] => 11/628730
[patent_app_country] => US
[patent_app_date] => 2005-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 18211
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184472.pdf
[firstpage_image] =>[orig_patent_app_number] => 11628730
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/628730 | Method of purifying environmental dna and method of efficiently screening for protein-encoding gene from environmental dna | Jun 7, 2005 | Abandoned |
Array
(
[id] => 4682950
[patent_doc_number] => 20080249176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Methods and Compositions for the Treatment of Myocardial Conditions'
[patent_app_type] => utility
[patent_app_number] => 10/594160
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12283
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249176.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594160
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594160 | Methods and Compositions for the Treatment of Myocardial Conditions | Apr 25, 2005 | Abandoned |
Array
(
[id] => 7136725
[patent_doc_number] => 20050181469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Beta-lactamase substrates having phenolic ethers'
[patent_app_type] => utility
[patent_app_number] => 11/093399
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9167
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181469.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093399 | Beta-lactamase substrates having phenolic ethers | Mar 28, 2005 | Abandoned |